Clinical trial finds new immunotherapy improves MS symptoms
A world-first clinical trial of a new cellular immunotherapy for multiple sclerosis (MS) has found that it improved symptoms and quality of life for most patients.
The CAHRLI Symposium is an annual event to showcase trailblazing allied health research, education initiatives and innovations, and provide an opportunity for health professionals to network and share ideas.